Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the antitumor efficacy AML model.
Long read sequencing revealed more genetic information in cases of 42 patients with rare diseases while cutting time and cost of diagnoses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback